AstraZeneca cancer drug Imfinzi gets USFDA priority review Medical Dialogues Bureau30 Nov 2019 9:40 AM ISTAstraZeneca said the USFDA accepted its supplemental application and granted priority review to Imfinzi for the treatment of previously untreated...
Cipla shares jump 2 pc post agreement with CitiHealth Imports Medical Dialogues Bureau30 Nov 2019 9:15 AM ISTNew Delhi: Shares of Cipla on Thursday rose nearly 2 per cent after the pharma major said its arm has signed an agreement with CitiHealth Imports to...
Medtronic drug-coated balloon IN.PACT AV gets USFDA nod to treat AV Fistulaes Medical Dialogues Bureau29 Nov 2019 12:33 PM ISTNew Delhi: Medtronic plc recently announced the U.S. Food and Drug Administration (USFDA) approval of the IN.PACT AV drug-coated balloon (DCB), a...
Novartis USD 90 million gene, cell therapy factory to begin Kymriah, Zolgensma production in 2020 Medical Dialogues Bureau29 Nov 2019 9:30 AM ISTNew Delhi: Swiss drugmaker Novartis's new $90 million Cell and Gene therapy factory in northern Switzerland is on track to begin commercial production...
Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list Medical Dialogues Bureau29 Nov 2019 9:15 AM ISTSeventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis treatment Omalizumab,...
ImmuPharma, Avion sign licensing agreement for lupus drug Lupuzor in US Medical Dialogues Bureau29 Nov 2019 9:00 AM ISTAvion and ImmuPharma will co-develop Lupuzor, including a new Phase III trial and Avion will commercialize the drug exclusively in the United States,...
UP Govt orders pull back of substandard Atorvastatin medicine from govt hospitals Farhat Nasim28 Nov 2019 2:14 PM ISTThe state government, hence, issued an order on November 19 to recall the entire batch of the medicine (Atorvastatin) that was supplied to more than ...
Cipla arm to acquire remaining 40 pc stake in Cipla Pharma Lanka for over Rs 1.5 lakh Medical Dialogues Bureau28 Nov 2019 2:11 PM ISTThe acquisition of 40 per cent stake is for a cash consideration of LKR 400,000 (over Rs 1.5 lakh) to be paid on closing of the transaction, Cipla...
Biocon, Mylan get USFDA nod for pegfilgrastim from new Bengaluru facility Medical Dialogues Bureau28 Nov 2019 9:45 AM IST"Biocon and Mylan's supplemental biologics licence application (sBLA) for pegfilgrastim drug substance to be manufactured in Biocon's new Biologics...
Centaur Pharma Ambernath facility receives EIR from USFDA Farhat Nasim28 Nov 2019 9:30 AM ISTCentaur Pharma has now received a formal EIR (Establishment Inspection Report) from USFDA stating the facility is CGMP compliant and the audit outcome...
Omega Healthcare appoints Sumit Sachdeva as Chief Growth Officer to expand pharma segment Medical Dialogues Bureau28 Nov 2019 9:10 AM ISTSumit Sachdeva brings over 20 years of experience in the Healthcare Services industry having held global positions strategizing and driving growth...
Pfizer, Novartis lead USD 2 billion spending spree on gene therapy production Medical Dialogues Bureau28 Nov 2019 9:00 AM ISTNew Delhi: Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018,...
